par Kaye, S B;Piccart-Gebhart, Martine ;Aapro, Matti;Francis, P;Kavanagh, J
Référence European journal of cancer, 33, 13, page (2167-2170)
Publication Publié, 1997-11
Référence European journal of cancer, 33, 13, page (2167-2170)
Publication Publié, 1997-11
Article révisé par les pairs
Titre: |
|
Auteur: | Kaye, S B; Piccart-Gebhart, Martine; Aapro, Matti; Francis, P; Kavanagh, J |
Informations sur la publication: | European journal of cancer, 33, 13, page (2167-2170) |
Statut de publication: | Publié, 1997-11 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Agents, Phytogenic -- adverse effects | |
Antineoplastic Agents, Phytogenic -- therapeutic use | |
CA-125 Antigen -- analysis | |
Clinical Trials, Phase II as Topic | |
Female | |
Humans | |
Middle Aged | |
Ovarian Neoplasms -- drug therapy | |
Paclitaxel -- adverse effects | |
Paclitaxel -- analogs & derivatives | |
Paclitaxel -- therapeutic use | |
Taxoids | |
Treatment Outcome | |
Tumor Markers, Biological -- analysis | |
Note générale: | Journal Article |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-8049 |
info:pii/S0959804997003638 | |
info:pmid/9470802 |